Scientific steering committee
Six experts were identified among Italian institutions, as
representative of specialists involved in medical care of patients with
CF. The scientific steering committee defined 11 statements divided into
the following seven main topics:
- Identification of the patient to be treated with mucoactive agents
- Identification of the pediatric patient to be treated with mucoactive
agents
- Definition of outcomes indicative of clinical benefit
- Criteria for choosing mucoactive agents
- Manageability of therapy with mucoactive agents
- Strategies to improve therapeutic adherence
- Physiotherapist’s role in managing therapy